Home LiteratureArticle Details
PMID: 16202857 Published · ppublish English Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Insulin-stimulated NAD(P)H oxidase activity increases migration of cultured vascular smooth muscle cells.

American journal of hypertension ·Vol. 18 ·No. 10 ·2005-10-00 ·Pages 1329-34

Yang M, Foster E, Kahn AM

Abstract

We reported that insulin stimulates NAD(P)H oxidase activity but not migration of cultured rat vascular smooth muscle cells (VSMCs). Because angiotensin II (Ang II) increases NAD(P)H oxidase activity in these cells, we wished to determine whether insulin stimulates migration of Ang II-treated VSMCs by synergistically stimulating enzyme activity. Cultured rat VSMC superoxide anion (O2-) production, cyclic GMP production, and migration were measured by lucigenin luminescence, immunoassay, and wound closure rate, respectively. Nitric oxide (NO) scavenging was measured by inhibition of NO-induced fluorescence of 4-5-diaminofluorescin. Insulin (1 nmol/L) did not affect and Ang II (100 nmol/L) stimulated VSMC migration by 65% (P < .05), but together stimulated it by 150% (P < .05 versus Ang II) by a mechanism inhibited by the NAD(P)H oxidase inhibitors, diphenyleneiodonium (DPI) or gp91ds-tat. Insulin and Ang II stimulated O2- production by 34% and 35%, respectively (both P < .05), but together synergistically stimulated it by 143% (P < .05 versus insulin or Ang II) in a DPI or gp91ds-tat-sensitive manner. Neither insulin nor Ang II measurably affected NO scavenging, but together reduced NO availability by 46% in a DPI-sensitive manner (P < .05) and significantly inhibited NO-stimulated cyclic GMP production. Insulin synergestically stimulates NAD(P)H oxidase activity in Ang II-treated cultured rat VSMCs causing increased migration.

MeSH Terms
Aminoquinolines/pharmacology Angiotensin II/pharmacology Animals Cell Movement/drug effects Cells, Cultured Cyclic GMP/metabolism Enzyme Inhibitors/pharmacology Glycoproteins/metabolism Guanylate Cyclase/antagonists & inhibitors Insulin/pharmacology Male Muscle, Smooth, Vascular/cytology,drug effects,metabolism NADPH Oxidases/metabolism Nitric Oxide Donors/pharmacology Onium Compounds/pharmacology Penicillamine/analogs & derivatives,pharmacology Rats Rats, Sprague-Dawley Superoxides/metabolism Vasoconstrictor Agents/pharmacology
Chemicals
Aminoquinolines Enzyme Inhibitors Glycoproteins Insulin Nitric Oxide Donors Onium Compounds S-nitro-N-acetylpenicillamine Vasoconstrictor Agents gp91ds-tat protein, chimeric Superoxides Angiotensin II diphenyleneiodonium 6-anilino-5,8-quinolinedione NADPH Oxidases Guanylate Cyclase Penicillamine Cyclic GMP
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Yang Ming
Division of Renal Diseases and Hypertension, Department of Internal Medicine, University of Texas Medical School, Houston, Texas 77030, USA.
Foster Estrella
Kahn Andrew M
Article Info
Journal
American journal of hypertension
Abbr.
Am J Hypertens
ISSN
0895-7061
Published
2005-10-00
Pages
1329-34
Language
English
Region
United States
NLM ID
8803676
Subset
IM
Grants
NHLBI NIH HHS · R01HL50660 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com